Article

A Promising Biomarker for Predicting Cardiovascular Risk in Asymptomatic Familial Hypercholesterolemia Patients From The SAFEHEART Study

2025-11-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Familial hypercholesterolemia (FH) is an autosomal dominant disorder associated with a markedly increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Genetic and molecular factors, including microRNAs (miRNAs), may serve as biomarkers to improve disease risk prediction. miRNAs are key regulators of biological processes involved in cardiovascular patholo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dbbdee1c-8850-52e1-83a5-5862f986e3c9
DOI: 10.1101/2025.11.03.25339452

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Promising Biomarker for Predicting Cardiovascular Risk in Asymptomatic Familial Hypercholesterolemia Patients From The SAFEHEART StudyDOI 10.1101/2025.11.03.25339452Read

Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.Semantic proximity Read

Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).Semantic proximity Read

Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis.Semantic proximity Read

Early atherosclerosis in familial hypercholesterolemia patients: significance of vascular markers for risk stratificationSemantic proximity Read

Genetic and molecular architecture of familial hypercholesterolemia.Semantic proximity Read

Familial Hypercholesterolemia: From Clinical Suspicion to Novel TreatmentsSemantic proximity Read

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial HypercholesterolemiaSemantic proximity Read

Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million PatientsSemantic proximity Read

European and Canadian derived risk prediction equations for atherosclerotic cardiovascular disease are valid in Australian patients with genetically confirmed familial hypercholesterolaemia.Semantic proximity Read

Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype.Semantic proximity Read

Beyond Cholesterol: A Comprehensive Review and Disease Architecture Reassessment of Lipid and Lipoprotein Biomarkers in ASCVDSemantic proximity Read

The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia.Semantic proximity Read